198 related articles for article (PubMed ID: 33813036)
21. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
[TBL] [Abstract][Full Text] [Related]
22. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
[TBL] [Abstract][Full Text] [Related]
23. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.
Haines ML; Ajlouni Y; Irving PM; Sparrow MP; Rose R; Gearry RB; Gibson PR
Inflamm Bowel Dis; 2011 Jun; 17(6):1301-7. PubMed ID: 20812329
[TBL] [Abstract][Full Text] [Related]
24. Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy.
Gasparetto M; Guariso G; Pozza LV; Ross A; Heuschkel R; Zilbauer M
BMC Gastroenterol; 2016 Mar; 16():35. PubMed ID: 26976427
[TBL] [Abstract][Full Text] [Related]
25. Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.
Saniabadi AR; Tanaka T; Ohmori T; Sawada K; Yamamoto T; Hanai H
World J Gastroenterol; 2014 Aug; 20(29):9699-715. PubMed ID: 25110409
[TBL] [Abstract][Full Text] [Related]
26. Increasing rates and changing patterns of hospital admissions for patients with inflammatory bowel disease in Ireland: 1996-2001.
Smyth CM; Picha SB; Rathore O; Deasy J; Patchett SE; Murray FE
Ir J Med Sci; 2005; 174(4):28-32. PubMed ID: 16445157
[TBL] [Abstract][Full Text] [Related]
27. Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs.
Zanoli L; Rastelli S; Inserra G; Lentini P; Valvo E; Calcagno E; Boutouyrie P; Laurent S; Castellino P
Atherosclerosis; 2014 Jun; 234(2):346-51. PubMed ID: 24732573
[TBL] [Abstract][Full Text] [Related]
28. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
29. Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease.
Verstockt B; Verstockt S; Dehairs J; Ballet V; Blevi H; Wollants WJ; Breynaert C; Van Assche G; Vermeire S; Ferrante M
EBioMedicine; 2019 Feb; 40():733-742. PubMed ID: 30685385
[TBL] [Abstract][Full Text] [Related]
30. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
31. Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease.
Baumgart DC; Thomas S; Przesdzing I; Metzke D; Bielecki C; Lehmann SM; Lehnardt S; Dörffel Y; Sturm A; Scheffold A; Schmitz J; Radbruch A
Clin Exp Immunol; 2009 Sep; 157(3):423-36. PubMed ID: 19664152
[TBL] [Abstract][Full Text] [Related]
32. Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants.
Andrisani G; Frasca D; Romero M; Armuzzi A; Felice C; Marzo M; Pugliese D; Papa A; Mocci G; De Vitis I; Rapaccini GL; Blomberg BB; Guidi L
J Crohns Colitis; 2013 May; 7(4):301-7. PubMed ID: 22673636
[TBL] [Abstract][Full Text] [Related]
33. Lower Sustained Diphtheria and Pertussis Antibody Concentrations in Inflammatory Bowel Disease Patients.
Caldera F; Saha S; Wald A; Garmoe CA; McCrone S; Megna B; Ley D; Reichelderfer M; Hayney MS
Dig Dis Sci; 2018 Jun; 63(6):1532-1540. PubMed ID: 29594970
[TBL] [Abstract][Full Text] [Related]
34. Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia.
Massuger W; Moore GTC; Andrews JM; Kilkenny MF; Reyneke M; Knowles S; Purcell L; Alex G; Buckton S; Page AT; Stocks N; Cameron D; Manglaviti F; Pavli P
Intern Med J; 2019 Jul; 49(7):859-866. PubMed ID: 30525299
[TBL] [Abstract][Full Text] [Related]
35. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
Ochsenkühn T; Sackmann M; Göke B
Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
[TBL] [Abstract][Full Text] [Related]
36. Effect of tumor necrosis factor-α inhibitors on drug-induced pancreatitis in inflammatory bowel disease.
Stobaugh DJ; Deepak P
Ann Pharmacother; 2014 Oct; 48(10):1282-7. PubMed ID: 24982311
[TBL] [Abstract][Full Text] [Related]
37. Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease.
Chupin A; Perduca V; Meyer A; Bellanger C; Carbonnel F; Dong C
Aliment Pharmacol Ther; 2020 Oct; 52(8):1289-1297. PubMed ID: 32840893
[TBL] [Abstract][Full Text] [Related]
38. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
39. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.
Serriari NE; Eoche M; Lamotte L; Lion J; Fumery M; Marcelo P; Chatelain D; Barre A; Nguyen-Khac E; Lantz O; Dupas JL; Treiner E
Clin Exp Immunol; 2014 May; 176(2):266-74. PubMed ID: 24450998
[TBL] [Abstract][Full Text] [Related]
40. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
